Aukera Therapeutics
PrivateLast Round
Seed
Dec 11, 2025
Total Funding Raised
$6.39M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Aukera Therapeutics operates in Healthcare & Life Sciences and is based in Basel. Its latest recorded funding round was a Seed round in December 2025.
Aukera Therapeutics is a biotechnology company developing therapies for mTOR-related disorders such as tuberous sclerosis.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aukera Therapeutics Comparables
Compare Aukera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aeovian Pharmaceuticals | 84% | |
| Cambrian Bio | 78% | |
| Johnson & Johnson | 74% |
For institutional investors. Book with your work email.
Aukera Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 11, 2025 | ||||
| Grant | Oct 19, 2022 | ||||
| Accelerator | Feb 21, 2022 |
For institutional investors. Book with your work email.
Aukera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kickfund | Seed |
| BaseLaunch | Accelerator |
| Venture Kick | Grant |
| Zurcher Kantonalbank | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 11, 2025
$6M raised from Zurcher Kantonalbank and Kickfund.
- Feb 21, 2022
$540K raised from BaseLaunch
For institutional investors. Book with your work email.
Aukera Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aukera Therapeutics's valuation, stock price, and market status.
Is Aukera Therapeutics a public or private company?
Aukera Therapeutics is a private company.
What is the current stock price of Aukera Therapeutics?
Aukera Therapeutics is a private company, so its shares have no public market price. Caplight tracks Aukera Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aukera Therapeutics worth (valuation)?
Valuation information for Aukera Therapeutics is not publicly available.
Can I buy Aukera Therapeutics stock?
Aukera Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aukera Therapeutics's last funding round?
Aukera Therapeutics's most recent funding round was Seed on December 11, 2025.
Who are the main investors in Aukera Therapeutics?
Key investors in Aukera Therapeutics include Kickfund, BaseLaunch, Venture Kick, Zurcher Kantonalbank.
Will Aukera Therapeutics IPO soon?
No public IPO plans have been announced for Aukera Therapeutics.
How can I track Aukera Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Aukera Therapeutics's shares on secondary markets.